Literature DB >> 31176433

MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and Toxicity.

Hamid Abdollahi1, Kiarash Tanha2, Bahram Mofid3, Abolfazl Razzaghdoust4, Afshin Saadipoor3, Leila Khalafi5, Mohsen Bakhshandeh6, Seied Rabi Mahdavi7.   

Abstract

BACKGROUND: The main purpose of this study was to assess the structural changes in the bladder wall of prostate cancer patients treated with intensity-modulated radiation therapy using magnetic resonance imaging texture features analysis and to correlate image texture changes with radiation dose and urinary toxicity.
METHODS: Ethical clearance was granted to enroll 33 patients into this study who were treated with intensity-modulated radiation therapy for prostate cancer. All patients underwent two magnetic resonance imagings before and after radiation therapy (RT). A total of 274 radiomic features were extracted from MR-T2W-weighted images. Wilcoxon singed rank-test was performed to assess significance of the change in mean radiomic features post-RT relative to pre-RT values. The relationship between radiation dose and feature changes was assessed and depicted. Cystitis was recorded as urinary toxicity. Area under receiver operating characteristic curve of a logistic regression-based classifier was used to find correlation between radiomic features with significant changes and radiation toxicity.
RESULTS: Thirty-three bladder walls were analyzed, with 11 patients developing grade ≥2 urinary toxicity. We showed that radiomic features may predict radiation toxicity and features including S5.0SumVarnc, S2.2SumVarnc, S1.0AngScMom, S0.4SumAverg, and S5. _5InvDfMom with area under receiver operating characteristic curve 0.75, 0.69, 0.65, 0.63, and 0.62 had highest correlation with toxicity, respectively. The results showed that most of the radiomic features were changed with radiation dose.
CONCLUSION: Feature changes have a good correlation with radiation dose and radiation-induced urinary toxicity. These radiomic features can be identified as being potentially important imaging biomarkers and also assessing mechanisms of radiation-induced bladder injuries.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Bladder wall; Feature changes; IMRT; MRI; Prostate cancer; Radiomics

Mesh:

Year:  2019        PMID: 31176433     DOI: 10.1016/j.jmir.2018.12.002

Source DB:  PubMed          Journal:  J Med Imaging Radiat Sci        ISSN: 1876-7982


  4 in total

1.  CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.

Authors:  Shayan Mostafaei; Hamid Abdollahi; Shiva Kazempour Dehkordi; Isaac Shiri; Abolfazl Razzaghdoust; Seyed Hamid Zoljalali Moghaddam; Afshin Saadipoor; Fereshteh Koosha; Susan Cheraghi; Seied Rabi Mahdavi
Journal:  Radiol Med       Date:  2019-09-24       Impact factor: 3.469

2.  Radiomic analysis of magnetic resonance fingerprinting in adult brain tumors.

Authors:  Sara Dastmalchian; Ozden Kilinc; Louisa Onyewadume; Charit Tippareddy; Debra McGivney; Dan Ma; Mark Griswold; Jeffrey Sunshine; Vikas Gulani; Jill S Barnholtz-Sloan; Andrew E Sloan; Chaitra Badve
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-26       Impact factor: 9.236

3.  Radiographic Texture Reproducibility: The Impact of Different Materials, their Arrangement, and Focal Spot Size.

Authors:  Younes Qasempour; Amirsalar Mohammadi; Mostafa Rezaei; Parisa Pouryazadanpanah; Fatemeh Ziaddini; Alma Borbori; Isaac Shiri; Ghasem Hajianfar; Azam Janati; Sareh Ghasemirad; Hamid Abdollahi
Journal:  J Med Signals Sens       Date:  2020-11-11

Review 4.  Radiomics in prostate cancer: an up-to-date review.

Authors:  Matteo Ferro; Ottavio de Cobelli; Gennaro Musi; Francesco Del Giudice; Giuseppe Carrieri; Gian Maria Busetto; Ugo Giovanni Falagario; Alessandro Sciarra; Martina Maggi; Felice Crocetto; Biagio Barone; Vincenzo Francesco Caputo; Michele Marchioni; Giuseppe Lucarelli; Ciro Imbimbo; Francesco Alessandro Mistretta; Stefano Luzzago; Mihai Dorin Vartolomei; Luigi Cormio; Riccardo Autorino; Octavian Sabin Tătaru
Journal:  Ther Adv Urol       Date:  2022-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.